• Join
  • Login
  • Contact

Search abstracts

The role of the pharmacist in the treatment of pediatric patients with infantile hemangioma using propranolol

  • At: Stockholm (Sweden) (2017)
  • Type: Poster
  • By: CASTANEDA, Saul (UABC, Pharmacy, Chula Vista, United States)
  • Co-author(s): Saul Castaneda: Pharmacy, UABC, Tijuana, United States
    Jose Luis Sanchez Palacio: Pharmacy, UABC, Tijuana, United States
    Hermelinda De la Cruz Duran: Pharmacy, Hospital Infantil de las Californias, Tijuana, Mexico
  • Abstract:


    Infantile hemangioma (IH) is the most common benign vascular tumors of childhood. Propranolol is considered the first-line treatment for this condition. Potentially there is a high probability of negative results to therapy, because in many countries there are no treatment protocols or propranolol formulations appropriate for the


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses